One UT San Antonio study found about 16% lower incidence in high-risk women with obesity. Discussant Rayjean Hung flagged biases that could inflate the effect.
Recap by typeshit. Full story at The ASCO Post.
Early uptake of the Wegovy pill outpaced injectable incretin weight loss drugs at a similar stage, HealthDay reported on Oct. 22.
Leftover food can't tell researchers whether someone stopped eating from fullness or from feeling sick, and Medical Xpress explains why that gap matters.
Moss says he once believed GLP-1s caused far more muscle loss than ordinary calorie cutting. He now says he got that wrong.
Topol points to neoantigens, the proteins or peptides on cancer cell surfaces, as the base of personalized cancer therapies.
The company announced exclusive manufacturing rights across its needle-free peptide products. Terms aren't given here.
Researchers found teaching emotion management alongside family behavioral treatment may help adolescents keep weight off once the program ends. No GLP-1 drugs involved.
Loading…